AstraZeneca Plc

By Olivia Oran April 30 (Reuters) - Life sciences-focused software company Veeva Systems is planning an initial public offering that could come in the third quarter and has selected banks to lead the deal, according to two people familiar with the...

Drug giant Pfizer Inc. has joined forces with competitor Merck & Co. Inc. to co-develop a new medicine for patients with type 2 diabetes, the companies announced Monday. Pfizer, which has a research-and-development site in Groton, currently has a...

Targacept Inc. said Monday it has completed the recruitment of patients in the Phase 2b study of the drug compound TC-1734 as a treatment for mild-to-moderate Alzheimer's disease. The Winston-Salem biotechnology company expects to report top-line...

Long Island scientists on the trail of health risks in everyday products say pure gold nanoparticles in cosmetics, pharmaceuticals and other medical substances may accelerate aging, increase wrinkling and slow the wound-healing process. The analysis,...

The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy. The Telegraph: GDP NUMBERS 'ENCOURAGING' BUT ROAD AHEAD IS NOT EASY - OSBORNE The better-than-...

* Rise in UK GDP lifts sterling, gilt yields * World shares gain for a 5th day on central bank hopes * Dollar under pressure from disappointing U.S. data * Gold, copper oil recover week's losses By Richard Hubbard LONDON, April 25 (Reuters) -...

LONDON, April 25 (Reuters) - AstraZeneca's sales fell by a bigger-than-expected 13 percent in the first quarter as patent expiries sent revenue from key medicines skidding lower, underscoring the turnaround challenge facing Britain's second biggest...

LONDRES, 25 abr (Reuters) - Las ventas de AstraZeneca disminuyeron más que lo previsto en un 13 por ciento en el primer trimestre debido a que el vencimiento de patentes cobró un precio muy alto, lo que subraya el desafío que enfrenta la segunda...

Reports: Initial jobless claims for week ended April 20, 7:30 a.m.; Mortgage rates for week ended April 25, 9 a.m.; Natural gas inventories for week ended April 20, 9:30 a.m.; Kansas City Fed manufacturing index for April, 10 a.m. Local earnings:...

LONDON, April 23 (Reuters) - Cash-rich drug companies are likely to make more acquisitions in 2013 after a thin year for deals in 2012, ratings agency Moody's Investors Service said on Tuesday. In an review of the global sector reiterating a "stable"...

Cambridge-based BIND Therapeutics and AstraZeneca said today they have entered into a strategic collaboration to develop and commercialize a cancer nanomedicine. Under terms of the agreement, the companies will work together to complete new drug-...

(Adds OPAP, Banca Carige, others) April 22 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Monday. ** The large and growing cash pile sitting on the books of Thai corporations has found another target as...